80 related articles for article (PubMed ID: 27999205)
1. MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity.
Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P
Oncotarget; 2017 Feb; 8(6):9216-9229. PubMed ID: 27999205
[TBL] [Abstract][Full Text] [Related]
2. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.
Tu MJ; Ho PY; Zhang QY; Jian C; Qiu JX; Kim EJ; Bold RJ; Gonzalez FJ; Bi H; Yu AM
Cancer Lett; 2019 Feb; 442():82-90. PubMed ID: 30389433
[TBL] [Abstract][Full Text] [Related]
3. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation.
Ma J; Weng L; Jia Y; Liu B; Wu S; Xue L; Yin X; Mao A; Wang Z; Shang M
J Cell Mol Med; 2020 Mar; 24(5):2917-2930. PubMed ID: 31989778
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV
Br J Cancer; 2016 Feb; 114(3):269-80. PubMed ID: 26766740
[TBL] [Abstract][Full Text] [Related]
5. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment.
Liu Q; Wu H; Li Y; Zhang R; Kleeff J; Zhang X; Cui M; Liu J; Li T; Gao J; Pan B; Wu W; Wang W; Zhou L; Guo J; Dai M; Zhang T; Liao Q; Lu Z; Zhao Y
Cancer Immunol Immunother; 2020 Aug; 69(8):1477-1492. PubMed ID: 32285172
[TBL] [Abstract][Full Text] [Related]
6. Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
Hawkins HJ; Yacob BW; Brown ME; Goldstein BR; Arcaroli JJ; Bagby SM; Hartman SJ; Macbeth M; Goodspeed A; Danhorn T; Lentz RW; Lieu CH; Leal AD; Messersmith WA; Dempsey PJ; Pitts TM
PLoS One; 2024; 19(4):e0298808. PubMed ID: 38598488
[TBL] [Abstract][Full Text] [Related]
7. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I
J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer.
Lei Y; Xu J; Xiao M; Wu D; Xu H; Yang J; Mao X; Pan H; Yu X; Shi S
Br J Cancer; 2024 May; 130(9):1505-1516. PubMed ID: 38454166
[TBL] [Abstract][Full Text] [Related]
9. Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.
Zhang Y; Yang C; Cheng H; Fan Z; Huang Q; Lu Y; Fan K; Luo G; Jin K; Wang Z; Liu C; Yu X
J Hematol Oncol; 2018 Jan; 11(1):14. PubMed ID: 29386069
[TBL] [Abstract][Full Text] [Related]
10. Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma.
Rana M; Kansal RG; Bisunke B; Fang J; Shibata D; Bajwa A; Yang J; Glazer ES
Mol Cancer Ther; 2023 Aug; 22(8):936-946. PubMed ID: 37294884
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T; Güngör C; Thieltges S; Möller-Krull M; Penas EM; Wicklein D; Streichert T; Schumacher U; Kalinin V; Simon R; Otto B; Dierlamm J; Schwarzenbach H; Effenberger KE; Bockhorn M; Izbicki JR; Yekebas EF
BMC Cancer; 2010 Jun; 10():295. PubMed ID: 20553613
[TBL] [Abstract][Full Text] [Related]
12. Circadian transcriptome of pancreatic adenocarcinoma unravels chronotherapeutic targets.
Sharma D; Adnan D; Abdel-Reheem MK; Anafi RC; Leary DD; Bishehsari F
JCI Insight; 2024 May; 9(9):. PubMed ID: 38716727
[TBL] [Abstract][Full Text] [Related]
13. Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
[TBL] [Abstract][Full Text] [Related]
14. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
[TBL] [Abstract][Full Text] [Related]
15. Identification of drugs that restore primary cilium expression in cancer cells.
Khan NA; Willemarck N; Talebi A; Marchand A; Binda MM; Dehairs J; Rueda-Rincon N; Daniels VW; Bagadi M; Thimiri Govinda Raj DB; Vanderhoydonc F; Munck S; Chaltin P; Swinnen JV
Oncotarget; 2016 Mar; 7(9):9975-92. PubMed ID: 26862738
[TBL] [Abstract][Full Text] [Related]
16. Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer.
Yang Y; Gu H; Zhang K; Guo Z; Wang X; Wei Q; Weng L; Han X; Lv Y; Cao M; Cao P; Huang C; Qiu Z
BMC Cancer; 2023 Aug; 23(1):789. PubMed ID: 37612627
[TBL] [Abstract][Full Text] [Related]
17. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review).
Zuzčák M; Trnka J
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35730611
[TBL] [Abstract][Full Text] [Related]
18. Targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer.
Zarei M; Hajihassani O; Hue JJ; Graor HJ; Rothermel LD; Winter JM
bioRxiv; 2023 Mar; ():. PubMed ID: 37034685
[TBL] [Abstract][Full Text] [Related]
19. Research progress in the establishment of pancreatic cancer models and preclinical applications.
Wu W; Wen K; Zhong Y
Cancer Innov; 2022 Oct; 1(3):207-219. PubMed ID: 38089760
[TBL] [Abstract][Full Text] [Related]
20. Cellular Repair of Synthetic Analogs of Oxidative DNA Damage Reveals a Key Structure-Activity Relationship of the Cancer-Associated MUTYH DNA Repair Glycosylase.
Conlon SG; Khuu C; Trasviña-Arenas CH; Xia T; Hamm ML; Raetz AG; David SS
ACS Cent Sci; 2024 Feb; 10(2):291-301. PubMed ID: 38435525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
